Shares of Moderna Inc.
MRNA,
shed 0.75% to $147.50 Thursday, on what proved to be an all-around tough buying and selling session for the inventory market, with the NASDAQ Composite Index
COMP,
falling 1.73% to 10,342.94 and Dow Jones Industrial Common
DJIA,
falling 0.46% to 32,001.25. This was the inventory’s second consecutive day of losses. Moderna Inc. closed $229.15 under its 52-week excessive ($376.65), which the corporate achieved on November twenty ninth.
The inventory demonstrated a blended efficiency when in comparison with a few of its rivals Thursday, as AbbVie Inc.
ABBV,
fell 0.07% to $144.42, Amgen Inc.
AMGN,
fell 1.16% to $265.88, and AstraZeneca PLC ADR
AZN,
rose 0.39% to $59.93. Buying and selling quantity (9.2 M) eclipsed its 50-day common quantity of 4.9 M.
Editor’s Word: This story was auto-generated by Automated Insights, an automation know-how supplier, utilizing information from Dow Jones and FactSet. See our market data terms of use.
